Odin Pharmaceuticals Registers Clinical Trial to Study Comparing Bimatoprost Ophthalmic Solution 0.01% with LUMIGAN (Bimatoprost Ophthalmic Solution) 0.01 % in Subjects with Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Source:
    Contify Life Science News. 2021.